drug protocol number

MK0431-083

drug sponsor

MSD

drug study

Sitagliptin

drug trial site

King Abdulaziz Medical City NG (Riyadh), King Abdulaziz Hospital NG (Al Ahsa), Al-Noor Specialist Hospital (Makkah)

drug status

Ongoing

drug phase